Skip to content

Intralesional Steroid Injections to Prevent Refractory Strictures in Patients with Esophageal Atresia

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504905-36-00
Acronym
NL65364.078.18
Enrollment
110
Registered
2024-01-11
Start date
2024-01-11
Completion date
Unknown
Last updated
2025-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strictures after esophageal atresia repair

Brief summary

The total number of dilatations within 28 days interval needed per patient during the study period, i.e. from the day of the study dilatation until 6 months later.

Interventions

DRUGKenacort-T 40 mg/ml injektionsvätska
DRUGsuspension
DRUGKenacort-A 10
DRUGsuspensie voor injectie 10 mg/ml

Sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Design outcomes

Primary

MeasureTime frame
The total number of dilatations within 28 days interval needed per patient during the study period, i.e. from the day of the study dilatation until 6 months later.

Countries

Denmark, Finland, France, Netherlands, Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026